JPMorgan Chase & Co. trimmed its stake in UiPath Inc. (NYSE:PATH - Free Report) by 78.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 950,541 shares of the company's stock after selling 3,551,243 shares during the period. JPMorgan Chase & Co. owned 0.17% of UiPath worth $12,081,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of UiPath by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 46,664,124 shares of the company's stock worth $593,101,000 after purchasing an additional 576,458 shares in the last quarter. Geode Capital Management LLC raised its holdings in UiPath by 7.2% during the third quarter. Geode Capital Management LLC now owns 7,312,068 shares of the company's stock valued at $93,619,000 after acquiring an additional 493,502 shares during the period. Raymond James Financial Inc. bought a new position in shares of UiPath in the fourth quarter worth about $5,506,000. Ieq Capital LLC raised its stake in UiPath by 29.7% during the 4th quarter. Ieq Capital LLC now owns 1,885,904 shares of the company's stock valued at $23,970,000 after purchasing an additional 431,451 shares during the period. Finally, Pacer Advisors Inc. lifted its holdings in UiPath by 698.1% in the 4th quarter. Pacer Advisors Inc. now owns 289,471 shares of the company's stock worth $3,679,000 after purchasing an additional 253,203 shares in the last quarter. 62.50% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on the stock. Barclays dropped their target price on shares of UiPath from $15.00 to $12.00 and set an "equal weight" rating for the company in a research report on Thursday, March 13th. Morgan Stanley decreased their target price on UiPath from $16.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. Mizuho reduced their price objective on UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a research note on Tuesday. Canaccord Genuity Group lowered their target price on UiPath from $19.00 to $14.00 and set a "buy" rating for the company in a research report on Thursday, March 13th. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $13.00 price target on shares of UiPath in a research report on Wednesday, March 26th. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $12.72.
Get Our Latest Stock Analysis on PATH
Insider Buying and Selling at UiPath
In related news, CAO Hitesh Ramani sold 12,500 shares of UiPath stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total transaction of $127,375.00. Following the completion of the sale, the chief accounting officer now owns 314,891 shares in the company, valued at $3,208,739.29. This trade represents a 3.82 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 22.37% of the stock is currently owned by corporate insiders.
UiPath Price Performance
Shares of PATH traded up $0.06 during mid-day trading on Friday, reaching $10.44. 11,973,213 shares of the company's stock traded hands, compared to its average volume of 10,487,091. The stock's 50-day moving average is $11.65 and its two-hundred day moving average is $12.79. UiPath Inc. has a 12 month low of $9.38 and a 12 month high of $20.95. The stock has a market cap of $5.76 billion, a P/E ratio of -65.25 and a beta of 1.04.
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
